Briefs: Alembic Pharmaceuticals and Tyche Industries
    Home » Drug Approval » Briefs: Alembic Pharmaceuticals and Tyche Industries
Drug Approval

Briefs: Alembic Pharmaceuticals and Tyche Industries

Alembic receives EIR from USFDA for facility at Panelav

  • By IPP Bureau | September 14, 2025

Alembic receives EIR from USFDA for facility at Panelav

Alembic Pharmaceuticals Limited has received Establishment Inspection Report (EIR) today for the inspection carried out by the US Food and Drug Administration (USFDA) at our API - I & API - II Facility located at Panelav. The inspection was conducted from 26th May, 2025 to 31st May, 2025.

Tyche Industries completes GMP inspection by ANVISA

Tyche Industries Limited has announced the successful completion of GMP inspection by Brazilian Health Regulatory agency, ANVISA during 1 week of September, 2025 at our Kakinada facility.

Upcoming E-conference

Other Related stories

Mankind Pharma gets CDSCO nod to begin Phase 1 trials of novel Autoimmune drug candidate MKP11093
FDA prohibits Sun Pharma's Halol Plant from exporting drugs to US
Alembic gets FDA final approval for Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single-Dose Prefilled Syringe
View More

Interviews

India rema
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex comm
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Our focus
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
View More

Appointments

Takeda appoints Rhonda Pacheco President of US Business Unit
Takeda appoints Rhonda Pacheco President of US Business Unit
Lonza appoints Jason Berndt as Head of Group Operations
Lonza appoints Jason Berndt as Head of Group Operations
Zydus Lifesciences appoints Nitin Parekh as President (Special Projects)
Zydus Lifesciences appoints Nitin Parekh as President (Special Projects)
View More

Startup

DPIIT signs MoU with Pfizer to strengthen India’s healthcare innovation ecosystem
DPIIT signs MoU with Pfizer to strengthen India’s healthcare innovation ecosystem
Healthium and C-CAMP launch innovations program for surgical and medical technologies
Healthium and C-CAMP launch innovations program for surgical and medical technologies
Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh
Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh
View More

Digitization

Lilly launches $1.1 billion TuneLab platform for AI-enabled drug discovery
Lilly launches $1.1 billion TuneLab platform for AI-enabled drug discovery
HealthEdge and UST HealthProof Merge to create AI-powered healthcare payer technology
HealthEdge and UST HealthProof Merge to create AI-powered healthcare payer technology
Dr. Lal PathLabs pioneers AI integration in cancer diagnosis in India
Dr. Lal PathLabs pioneers AI integration in cancer diagnosis in India
View More

Latest Stories

Yatharth Hospitals acquires Shantived Hospital in Agra for Rs. 260 Cr

Briefs: Alembic Pharmaceuticals and Tyche Industries

Fermenta granted process patent for plant-based Vitamin D3

Takeda appoints Rhonda Pacheco President of US Business Unit

Biocon Foundation constructs new high school building in Karnataka

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging
UFlex secures Indian patent for waterborne heat seal coating for food, consumer goods packaging
UFlex secures Indian patent for waterborne heat seal coating for food, consumer goods packaging
Sanner commences manufacturing critical injection-molded components in USA
Sanner commences manufacturing critical injection-molded components in USA
UFlex introduces FSSAI compliant single-pellet solution for food packaging
UFlex introduces FSSAI compliant single-pellet solution for food packaging